Skip to main content
VTGN logo

VTGN · Vistagen Therapeutics, Inc. · Analyst Estimates

Track VTGN — free
$0.24 0.00 (-0.84%) At close · Sep 11
Market Cap
$10.52M
Shares
44.38M

Analyst Estimates

Compare analyst forecasts for Vistagen Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1411685 CUSIP 92840H400 13F (30d) 22 filings 22 filers Visit website Investor relations